
- Telehealth Visits
- Insurance plan information


Jacque L. Duncan, MD
Retina and Vitreous Diseases • Pediatric Ophthalmology- Telehealth Visits
- Insurance plan information




Jacque L. Duncan, MD
Retina and Vitreous Diseases • Pediatric Ophthalmology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jacque Duncan is an ophthalmologist who specializes in treating retinal degenerative diseases, such as retinitis pigmentosa, which affects one in 3,500 people worldwide, and age-related macular degeneration, the leading cause of blindness in Americans over age 50. Both conditions run in families and have no cure. In addition, her expertise includes diagnosing and treating retinal diseases such as Usher syndrome (an inherited disorder that affects both vision and hearing), cone-rod dystrophy (an inherited disorder in which the retina's light-sensitive cells deteriorate) and Stargardt disease (a form of macular degeneration that develops in childhood). She is skilled in using experimental techniques to prevent or slow these conditions.
In her research, Duncan is studying treatments to preserve vision as well as devices to stimulate visual perception. She has received research funding from Research to Prevent Blindness, the Karl Kirchgessner Foundation, Hope for Vision and the American Geriatrics Society, in addition to receiving a Career Development Award from the Foundation Fighting Blindness.
Duncan earned her medical degree at UCSF, where she also completed an ophthalmology residency. She then completed a medical retina fellowship at the Penn Medicine Scheie Eye Institute, where she focused on patients with age-related macular degeneration and inherited retinal degeneration. She joined the UCSF faculty in 2000.
Education & training
Board certification
- Ophthalmology, American Board of Ophthalmology
Fellowship
- Ophthalmology, Scheie Eye Institute
Residency
- Ophthalmology, UCSF HR/Employment Verification
Internship
- Internal Medicine, UCSF Medical Center - OMAG
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
- Retina and Vitreous Diseases
- Pediatric Ophthalmology
Conditions
- Retinoschisis
- Retinitis Pigmentosa
- Leber Congenital Amaurosis
- Eye Diseases
- Diabetic Eye Disease
- Macular Degeneration
Locations

Doctors see bright future for augmented sight
My research
Clinical trials
Retinal Imaging in Patients With Inherited Retinal DegenerationsOpens in a new window
Recruiting
The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.EyeConic: Qualification for Cone-OptogeneticsOpens in a new window
Recruiting
Number of participants with preserved central retinal volumeStudy to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)Opens in a new window
Recruiting
To evaluate the safety and tolerability of a single dose of ACDN-01 when administered to participants with ABCA4-related retinopathy.
Publications
Showing 1-6 of 40 reviews
- January 30, 20265 out of 5 Stars
Dr. Duncan is amazing!! She is extremely professional - she explained what she saw, she explained what options are available and which she recommends, and then she asked me for my thoughts. She was also concerned about me and my life. I have experience with other providers in the Retina Clinic and Dr. Duncan is clearly a step above the rest!!
- January 27, 20265 out of 5 Stars
Dr. Duncan is always engaging and informative. I value her care for my condition.
- December 18, 20255 out of 5 Stars
Excellent
- November 25, 20255 out of 5 Stars
Absolutely top notch
- November 11, 20255 out of 5 Stars
Dr Duncan is awesome
- November 2, 20255 out of 5 Stars
Jacque Duncan is one of my favorite Doctors and this is saying a lot, I have a barrage of health conditions that I am managing, surveillance for past cancers etc... And she has helped me understand and manage my eye condition. She is sparkly and caring and incredibly knowledgeable. I feel better every time I see her. She is a gem.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.